基斯勒和尼茨曼的血分离方法.

H Friedli, J J Morgenthaler

Lancet (London, England)

|May 25, 1985

概括

No abstract available in PubMed .

相关概念视频

您也可能阅读

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

WHO Expert Committee on Biological Standardization.

World Health Organization technical report series·2005

Same author

Securing viral safety for plasma derivatives.

Transfusion medicine reviews·2001

Same author

New developments in plasma fractionation and virus inactivation.

Vox sanguinis·2000

Same author

Virus inactivation by pepsin treatment at pH 4 of IgG solutions: factors affecting the rate of virus inactivation.

Transfusion·1996

Same author

Effects of intravenous infusion of lipid-free apo A-I in humans.

Arteriosclerosis, thrombosis, and vascular biology·1996

Same author

Cellular processing of copper-67-labeled monoclonal antibody chCE7 by human neuroblastoma cells.

Cancer research·1995

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

查看所有相关文章

相关实验视频

基斯勒和尼茨曼的血分离方法.

相关概念视频

WHO Expert Committee on Biological Standardization.

Securing viral safety for plasma derivatives.

New developments in plasma fractionation and virus inactivation.

Virus inactivation by pepsin treatment at pH 4 of IgG solutions: factors affecting the rate of virus inactivation.

Effects of intravenous infusion of lipid-free apo A-I in humans.

Cellular processing of copper-67-labeled monoclonal antibody chCE7 by human neuroblastoma cells.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

基斯勒和尼茨曼的血分离方法.

相关概念视频

WHO Expert Committee on Biological Standardization.

Securing viral safety for plasma derivatives.

New developments in plasma fractionation and virus inactivation.

Virus inactivation by pepsin treatment at pH 4 of IgG solutions: factors affecting the rate of virus inactivation.

Effects of intravenous infusion of lipid-free apo A-I in humans.

Cellular processing of copper-67-labeled monoclonal antibody chCE7 by human neuroblastoma cells.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.